SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001765581-19-000094
Filing Date
2019-11-08
Accepted
2019-11-08 18:24:08
Documents
1
Period of Report
2019-11-07

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 3565
  Complete submission text file 0001765581-19-000094.txt   5034
Mailing Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4
Business Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4 353-1-634-7800
Jazz Pharmaceuticals plc (Issuer) CIK: 0001232524 (see all company filings)

IRS No.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 3170 PORTER DRIVE PALO ALTO CA 94304
Business Address
Larkin Finbar (Reporting) CIK: 0001793243 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33500 | Film No.: 191205280